Study on Predictive Biomarkers of Neoadjuvant Chemoradiotherapy for Rectal Cancer
Conditions: Rectal Neoplasm Malignant Carcinoma; Chemoradiotherapy; Neoadjuvant Therapy; Predictive Biomarkers; Adenocarcinoma Interventions: Radiation: Radiation; Drug: Capecitabine-Irinotecan Combination Sponsors: Fudan University; Liaoning Tumor Hospital & Institute; Harbin Medical University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Carcinoma | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Radiation Therapy | Neoadjuvant Therapy | Rectal Cancers | Research | Study | Xeloda